Skip to main content

Estazolam Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Oct 20, 2021.

Estazolam is also known as: Prosom

Estazolam Pregnancy Warnings

Several studies have suggested an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy. There are no adequate studies in pregnant women.

US FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

Use is contraindicated.

US FDA pregnancy category: X

-The child born to a mother taking benzodiazepines may be at risk for withdrawal symptoms.
-Benzodiazepines may cause fetal damage when administered during pregnancy.
-The patient should be warned of the potential risks to the fetus and instructed to discontinue the drug prior to becoming pregnant.

See references

Estazolam Breastfeeding Warnings

Use is not recommended.

Excreted into human milk: Data not available
Excreted into animal milk: Yes

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. Product Information. Prosom (estazolam). Abbott Pharmaceutical. 2022.

References for breastfeeding information

  1. Product Information. Prosom (estazolam). Abbott Pharmaceutical. 2022.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.